Stay updated on GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial

Sign up to get notified when there's something new on the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The Record History now lists Revision: v3.5.4 as the latest release, replacing the previous v3.5.3. This reflects a routine site update rather than changes to study records.
    Difference
    0.1%
    Check dated 2026-05-16T10:23:18.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from v3.5.2 to v3.5.3, indicating a UI or system release with no change to the underlying study record fields.
    Difference
    0.1%
    Check dated 2026-04-25T05:21:31.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and deleted Revision: v3.5.0 in the study record history.
    Difference
    0.1%
    Check dated 2026-04-17T23:56:39.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    A new site revision v3.5.0 was added to the record history, and revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T03:28:38.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Latest revision updated to v3.4.3, replacing the previous v3.4.2 in the page history.
    Difference
    0.1%
    Check dated 2026-03-11T18:00:26.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Revision v3.4.2 was added to the history; the prior funding notice and v3.4.1 entry were removed.
    Difference
    0.8%
    Check dated 2026-02-11T02:33:31.000Z thumbnail image

Stay in the know with updates to GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page.